New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Studies suggest these drugs can reduce body weight by up to 22.5% over 72 weeks hence, it is crucial to be aware of potential risks and side ... data is needed.” Ozempic, a drug for diabetics ...

Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy ... a week later she was rushed to hospital after experiencing 'massive blood clots'. She was then referred to a colorectal ...

Ozempic, a diabetes drug ... constipation, and possible risks for pancreatitis or gallbladder issues in some people. So, it’s not a universal fix—but it could be a huge step forward for ...